Next Article in Journal
Potential Roles of Dec and Bmal1 Genes in Interconnecting Circadian Clock and Energy Metabolism
Next Article in Special Issue
In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators
Previous Article in Journal
Cell-Penetrating Function of the Poly(ADP-Ribose) (PAR)-Binding Motif Derived from the PAR-Dependent E3 Ubiquitin Ligase Iduna
Previous Article in Special Issue
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
Review

The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases

1
Department of Microbiology and Immunology, National Defense Medical Center, No.161, Section 6, Min Chuan East Road, Neihu, Taipei 114, Taiwan
2
Graduate Institute of Life Sciences, National Defense Medical Center, No. 161, Section 6, Min Chuan East Road, Neihu, Taipei 114, Taiwan
3
Molecular Cell Biology, Taiwan International Graduate Program, Academia Sinica, Taipei 115, Taiwan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(3), 780; https://doi.org/10.3390/ijms19030780
Received: 31 January 2018 / Revised: 28 February 2018 / Accepted: 6 March 2018 / Published: 8 March 2018
(This article belongs to the Special Issue Glycosylation and Glycoproteins 2017)
Glycosylation is a ubiquitous posttranslational modification of proteins that occurs in the endoplasmic reticulum/Golgi. N-glycans and mucin-type O-glycans are achieved via a series of glycohydrolase- and glycosyltransferase-mediated reactions. Glycosylation modulates immune responses by regulating thymocyte development and T helper cell differentiation. Autoimmune diseases result from an abnormal immune response by self-antigens and subsequently lead to the destruction of the target tissues. The modification of N-glycans has been studied in several animal models of T-cell-mediated autoimmune diseases. This review summarizes and highlights the modulatory effects of N-glycosylation in several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, and type 1 diabetes mellitus. View Full-Text
Keywords: N-glycan; O-glycan; autoimmune disease; multiple sclerosis; inflammatory bowel disease systemic lupus erythematosus; type 1 diabetes mellitus N-glycan; O-glycan; autoimmune disease; multiple sclerosis; inflammatory bowel disease systemic lupus erythematosus; type 1 diabetes mellitus
Show Figures

Figure 1

MDPI and ACS Style

Chien, M.-W.; Fu, S.-H.; Hsu, C.-Y.; Liu, Y.-W.; Sytwu, H.-K. The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases. Int. J. Mol. Sci. 2018, 19, 780. https://doi.org/10.3390/ijms19030780

AMA Style

Chien M-W, Fu S-H, Hsu C-Y, Liu Y-W, Sytwu H-K. The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases. International Journal of Molecular Sciences. 2018; 19(3):780. https://doi.org/10.3390/ijms19030780

Chicago/Turabian Style

Chien, Ming-Wei, Shin-Huei Fu, Chao-Yuan Hsu, Yu-Wen Liu, and Huey-Kang Sytwu. 2018. "The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases" International Journal of Molecular Sciences 19, no. 3: 780. https://doi.org/10.3390/ijms19030780

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop